Will molecular jackhammers have at least 50% tumour-free efficacy in Phase 2 clinical trials?
Gezondheid en geneeskundeOne-Off1jManifold MarketsGeen KYCGeverifieerde afwikkelingsgegevensRedelijk gekalibreerdHuidige gemeenschapsvoorspellingNee 80%
Voorspellers
10
Vraagtype
binary
Methodologie
Play-money forecasting platform
Brontype
Voorspelling
Marktdata
Bijgewerkt 9 uur geleden
Verouderd31 dec 23, 16:21 UTC2 jan 28, 07:59 UTC
Trends
Regels
See the paper Molecular Jackhammers Eradicate Cancer Cells By Vibronic-Driven Action in the journal Nature Chemistry https://twitter.com/burny_tech/status/1741300258406031421/photo/1
- If at the end date, I confirm that clinical trials are actively moving forward, the end date will be extended.
- Market will resolve early if I find out that researchers have decided that they are not moving forward.
- (reworded Jan 3, 2024)
